A potent and selective αVβ3 integrin inhibitor with an IC50 of 20 nM.
CAT No: R1823
CAS No:217099-14-4
Synonyms/Alias:217099-14-4;Cyclo(RGDyK);cyclo[Arg-Gly-Asp-D-Tyr-Lys];Cyclo(-Arg-Gly-Asp-D-Tyr-Lys) trifluoroacetate salt;CHEMBL2071605;2-[(2S,5R,8S,11S)-8-(4-aminobutyl)-11-[3-(diaminomethylideneamino)propyl]-5-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid;cyclo(Arg-Gly-Asp-D-Tyr-Lys);cyclo-(Arg-Gly-Asp-d-Tyr-Lys);cyclo-[Arg-Gly-Asp-d-Tyr-Lys];Cyclo(L-arginylglycyl-L-|A-aspartyl-D-tyrosyl-L-lysyl);SCHEMBL7746029;BDBM50390492;AT42662;HY-100563A;DA-52216;FC110223;CS-0100470;
4. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
5. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More